Early growth response 3 (Egr3) is highly over-expressed in non-relapsing prostate cancer but not in relapsing prostate cancer.

Members of the early growth response (EGR) family of transcription factors play diverse functions in response to many cellular stimuli, including growth, stress, and inflammation. Egr3 has gone relatively unstudied, but here through use of the SPECS (Strategic Partners for the Evaluation of Predicti...

全面介绍

书目详细资料

Principais autores:	Rebecca Pio, Zhenyu Jia, Veronique T Baron, Dan Mercola, UCI NCI SPECS Consortium of the Strategic Partners for the Evaluation of Cancer Signatures-Prostate Cancer
格式:	Artigo
语言:	Inglês
出版:	Public Library of Science (PLoS) 2013-01-01
丛编:	PLoS ONE
在线阅读:	http://europepmc.org/articles/PMC3544741?pdf=render
标签:	添加标签 没有标签, 成为第一个标记此记录!